Nano-X Imaging (NNOX) Non-Current Assets (2019 - 2026)
Nano-X Imaging's (NNOX) quarterly Non-Current Assets came in at $94.4 million in Q1 2026, down 26.66% YoY from $128.8 million in Q1 2025, and down 0.98% on a QoQ basis from $95.4 million in Q4 2025.
Nano-X Imaging (NNOX) Non-Current Assets (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has 8 years of Non-Current Assets data on file, last reported at $94.4 million in Q1 2026.
- Quarterly Non-Current Assets fell 26.66% year-over-year to $94.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.4 million (down 26.66% YoY) and the FY2025 annual result came in at $95.4 million, down 27.38% from the prior year.
- Non-Current Assets eased to $94.4 million in Q1 2026, from $95.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $269.1 billion in Q1 2022 to a low of $94.4 million in Q1 2026.
- A 5-year average of $42.0 billion and a median of $130.0 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 1203873.15% — and 2023, when it tumbled 99.94%.
- Tracing NNOX's Non-Current Assets over 5 years: stood at $171.5 million in 2022, then slipped by 24.18% to $130.0 million in 2023, then advanced by 1.01% to $131.3 million in 2024, then slipped by 27.38% to $95.4 million in 2025, then retreated by 0.98% to $94.4 million in 2026.
- The last three Non-Current Assets figures came in at $94.4 million (Q1 2026), $95.4 million (Q4 2025), and $124.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Nano-X Imaging | 61,578.01 | -44.16 Mn | -2.59 Mn | 94.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.44 Mn |
| Dec 31, 2025 | 95.37 Mn |
| Sep 30, 2025 | 124.77 Mn |
| Jun 30, 2025 | 126.75 Mn |
| Mar 31, 2025 | 128.77 Mn |
| Dec 31, 2024 | 131.32 Mn |
| Sep 30, 2024 | 123.50 Mn |
| Jun 30, 2024 | 126.10 Mn |
| Mar 31, 2024 | 126.84 Mn |
| Dec 31, 2023 | 130.01 Mn |
| Sep 30, 2023 | 133.69 Mn |
| Jun 30, 2023 | 147.37 Mn |
| Mar 31, 2023 | 157.11 Mn |
| Dec 31, 2022 | 171.47 Mn |
| Sep 30, 2022 | 215.08 Bn |
| Jun 30, 2022 | 227.96 Bn |
| Mar 31, 2022 | 269.09 Bn |
| Dec 31, 2021 | 268.31 Mn |
| Sep 30, 2021 | 106.39 Mn |
| Jun 30, 2021 | 68.53 Mn |